Probiotics for intestinal decolonization of ESBL-producing enterobacteriaceae; a randomized, placebo-controlled clinical trial
OBJECTIVES: Infections with extended spectrum beta-lactamase (ESBL) producing Enterobacteriaceae (EPE) are a major healthcare concern. Our goal was to investigate whether a probiotic mixture could be used for eradication therapy in patients with prolonged intestinal EPE carriage.METHODS: We performed a randomized, placebo-controlled single blinded clinical superiority trial in the south of Sweden
